NASDAQ:RARE | Revenue | Ultragenyx Pharmaceutical Inc.

Complete source-backed revenue history.

Available history
2016-12-31 to 2026-06-30
Data captured

Historical Revenue

DateRevenue
2026-06-30$214M
2026-03-31$136M
2025-12-31$207.28M
2025-09-30$159.93M
2025-06-30$167M
2025-03-31$139M
2024-12-31$164.65M
2024-09-30$139.49M
2024-06-30$147.03M
2024-03-31$108.83M
2023-12-31$127.14M
2023-09-30$98.05M
2023-06-30$108.31M
2023-03-31$100.5M
2022-12-31$103.35M
2022-09-30$90.7M
2022-06-30$89.34M
2022-03-31$79.94M
2021-12-31$83.39M
2021-09-30$81.65M
2021-06-30$86.98M
2021-03-31$99.4M
2020-12-31$91.54M
2020-09-30$81.47M
2020-06-30$61.71M
2020-03-31$36.31M
2019-12-31$35.59M
2019-09-30$25.8M
2019-06-30$24.15M
2019-03-31$18.17M
2018-12-31$16.26M
2018-09-30$11.76M
2018-06-30$12.79M
2018-03-31$10.68M
2017-12-31$2.41M
2017-09-30$198,000.00

Annual Revenue

DateRevenue
2025-12-31$673M
2024-12-31$560M
2023-12-31$434M
2022-12-31$363.33M
2021-12-31$351.41M
2020-12-31$271.03M
2019-12-31$103.71M
2018-12-31$51.5M
2017-12-31$2.61M
2016-12-31$133,000.00